AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 318 filers reported holding AVANOS MED INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $784,536 | +231.1% | 38,800 | +318.6% | 0.03% | +222.2% |
| Q2 2023 | $236,941 | -19.6% | 9,270 | -6.5% | 0.01% | -25.0% |
| Q1 2023 | $294,813 | -27.2% | 9,913 | -33.8% | 0.01% | -50.0% |
| Q4 2022 | $405,115 | -53.4% | 14,971 | -62.5% | 0.02% | -55.6% |
| Q3 2022 | $870,000 | -33.7% | 39,960 | +2.1% | 0.05% | +5.9% |
| Q1 2022 | $1,312,000 | +6.7% | 39,153 | +10.4% | 0.05% | -7.3% |
| Q4 2021 | $1,230,000 | -35.6% | 35,472 | -42.0% | 0.06% | -49.5% |
| Q3 2021 | $1,910,000 | +618.0% | 61,210 | +955.3% | 0.11% | +808.3% |
| Q4 2020 | $266,000 | -19.4% | 5,800 | -41.6% | 0.01% | -20.0% |
| Q3 2020 | $330,000 | -56.8% | 9,939 | -65.0% | 0.02% | -72.7% |
| Q1 2020 | $764,000 | -66.4% | 28,360 | -57.9% | 0.06% | -45.0% |
| Q4 2019 | $2,273,000 | +967.1% | 67,437 | +1087.7% | 0.10% | +809.1% |
| Q3 2019 | $213,000 | -92.2% | 5,678 | -91.1% | 0.01% | -93.3% |
| Q1 2019 | $2,720,000 | +83.8% | 63,735 | +92.9% | 0.16% | +39.8% |
| Q4 2018 | $1,480,000 | – | 33,032 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,310,272 | $63,163,000 | 4.83% |
| RGM Capital, LLC | 2,978,889 | $81,443,000 | 4.25% |
| Tributary Capital Management, LLC | 586,117 | $16,024,000 | 1.59% |
| HEARTLAND ADVISORS INC | 395,141 | $10,803,000 | 0.75% |
| Hillsdale Investment Management Inc. | 169,400 | $4,631,000 | 0.37% |
| WESTWOOD HOLDINGS GROUP INC | 1,068,905 | $29,225,000 | 0.32% |
| Keene & Associates, Inc. | 11,642 | $318,000 | 0.30% |
| Wakefield Asset Management LLLP | 24,356 | $666,000 | 0.28% |
| CORNERCAP INVESTMENT COUNSEL INC | 36,025 | $985,000 | 0.17% |
| GSA CAPITAL PARTNERS LLP | 26,366 | $721,000 | 0.11% |